Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Eval. of the Efficacy of Ridaforolimus)(8669-011)

This study is ongoing, but not recruiting participants.

Study NCT00538239 Information provided by Merck

First Received: September 28, 2007 Last Updated: July 7, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	January 2012
Primary Completion Date:	October 2010 (Final data collection date for primary outcome measure)